Hypoaldosteronism risk factors: Difference between revisions
Jump to navigation
Jump to search
Akshun Kalia (talk | contribs) No edit summary |
Akshun Kalia (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of hypoaldosteronism include diabetes mellitus, sickle cell anemia, HIV, [[graves' disease]], [[hypoparathyroidism]], [[hypopituitarism]] [[myasthenia gravis]], and [[pernicious anemia]]. Other less common risk factors include multiple myeloma, SLE-associated renal disease and Wolmans disease | Common risk factors in the development of hypoaldosteronism include diabetes mellitus, sickle cell anemia, HIV, [[graves' disease]], [[hypoparathyroidism]], [[hypopituitarism]] [[myasthenia gravis]], and [[pernicious anemia]]. Other less common risk factors include multiple myeloma, SLE-associated renal disease and Wolmans disease. | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of hypoladosteronism include:<ref name="pmid2141843">{{cite journal |vauthors=Uribarri J, Oh MS, Carroll HJ |title=Hyperkalemia in diabetes mellitus |journal=J Diabet Complications |volume=4 |issue=1 |pages=3–7 |year=1990 |pmid=2141843 |doi= |url=}}</ref><ref name="pmid11967822">{{cite journal |vauthors=Bojestig M, Nystrom FH, Arnqvist HJ, Ludvigsson J, Karlberg BE |title=The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes |journal=J Renin Angiotensin Aldosterone Syst |volume=1 |issue=4 |pages=353–6 |year=2000 |pmid=11967822 |doi=10.3317/jraas.2000.065 |url=}}</ref> | |||
*[[Diabetes mellitus]] | |||
*Sicke cell anemia | |||
*HIV | |||
*[[Graves' disease]] | |||
*[[Hypoparathyroidism]] | |||
*[[Hypopituitarism]] | |||
*[[Myasthenia gravis]] | |||
*[[Pernicious anemia]] | |||
===Less Common Risk Factors=== | ===Less Common Risk Factors=== | ||
Less common risk factors in the development of hypoaldosteronism include:<ref name="pmid8222376">{{cite journal |vauthors=Shaked Y, Blau A, Shpilberg O, Samra Y |title=Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up |journal=Clin. Nephrol. |volume=40 |issue=2 |pages=79–82 |year=1993 |pmid=8222376 |doi= |url=}}</ref> | |||
*Multiple myeloma | |||
*SLE-associated renal disease. | |||
*Wolmans disease | |||
==References== | ==References== | ||
Revision as of 19:25, 25 August 2017
|
Hypoaldosteronism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypoaldosteronism risk factors On the Web |
|
American Roentgen Ray Society Images of Hypoaldosteronism risk factors |
|
Risk calculators and risk factors for Hypoaldosteronism risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Common risk factors in the development of hypoaldosteronism include diabetes mellitus, sickle cell anemia, HIV, graves' disease, hypoparathyroidism, hypopituitarism myasthenia gravis, and pernicious anemia. Other less common risk factors include multiple myeloma, SLE-associated renal disease and Wolmans disease.
Risk Factors
Common risk factors in the development of hypoladosteronism include:[1][2]
- Diabetes mellitus
- Sicke cell anemia
- HIV
- Graves' disease
- Hypoparathyroidism
- Hypopituitarism
- Myasthenia gravis
- Pernicious anemia
Less Common Risk Factors
Less common risk factors in the development of hypoaldosteronism include:[3]
- Multiple myeloma
- SLE-associated renal disease.
- Wolmans disease
References
- ↑ Uribarri J, Oh MS, Carroll HJ (1990). "Hyperkalemia in diabetes mellitus". J Diabet Complications. 4 (1): 3–7. PMID 2141843.
- ↑ Bojestig M, Nystrom FH, Arnqvist HJ, Ludvigsson J, Karlberg BE (2000). "The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes". J Renin Angiotensin Aldosterone Syst. 1 (4): 353–6. doi:10.3317/jraas.2000.065. PMID 11967822.
- ↑ Shaked Y, Blau A, Shpilberg O, Samra Y (1993). "Hyporeninemic hypoaldosteronism associated with multiple myeloma: 11 years of follow-up". Clin. Nephrol. 40 (2): 79–82. PMID 8222376.